Dose Optimization of Anxiolytic Compounds Group in Valeriana jatamansi Jones and Mechanism Exploration by Integrating Network Pharmacology and Metabolomics Analysis
文献类型:期刊论文
作者 | Zhao, Chengbowen2,3; Wei, Xiaojia3; Guo, Jianyou1; Ding, Yongsheng3; Luo, Jing3; Yang, Xue3; Li, Jiayuan3; Wan, Guohui3; Yu, Jiahe3; Shi, Jinli3 |
刊名 | BRAIN SCIENCES |
出版日期 | 2022-05-01 |
卷号 | 12期号:5页码:21 |
关键词 | Valeriana jatamansi Jones anxiety disorder network pharmacology metabolomics arachidonic acid metabolism |
DOI | 10.3390/brainsci12050589 |
通讯作者 | Shi, Jinli(shijl@bucm.edu.com) |
英文摘要 | Anxiety disorder impacts the quality of life of the patients. The 95% ethanol extract of rhizomes and roots of Valeriana jatamansi Jones (Zhi zhu xiang, ZZX) has previously been shown to be effective for the treatment of anxiety disorder. In this study, the dose ratio of each component of the anxiolytic compounds group (ACG) in a 95% ethanol extract of ZZX was optimized by a uniform design experiment and mathematical modeling. The anxiolytic effect of ACG was verified by behavioral experiments and biochemical index measurement. Network pharmacology was used to determine potential action targets, as well as predict biological processes and signaling pathways, which were then verified by molecular docking analysis. Metabolomics was then used to screen and analyze metabolites in the rat hippocampus before and after the administration of ZZX-ACG. Finally, the results of metabolomics and network pharmacology were integrated to clarify the anti-anxiety mechanism of the ACG. The optimal dose ratio of ACG in 95% ethanol extract of ZZX was obtained, and our results suggest that ACG may regulate ALB, AKT1, PTGS2, CYP3A4, ESR1, CASP3, CYP2B6, EGFR, SRC, MMP9, IGF1, and MAPK8, as well as the prolactin signaling pathway, estrogen signaling pathway, and arachidonic acid metabolism pathway, thus affecting the brain neurotransmitters and HPA axis hormone levels to play an anxiolytic role, directly or indirectly. |
收录类别 | SCI |
WOS关键词 | ANXIETY ; ESTROGEN ; RECEPTOR ; STRESS ; EXPRESSION ; PROLACTIN ; APOPTOSIS ; AMYGDALA ; EXTRACT ; GPR30 |
资助项目 | National Natural Science Foundation of China[81673560] ; National Natural Science Foundation of China[82073971] |
WOS研究方向 | Neurosciences & Neurology |
语种 | 英语 |
出版者 | MDPI |
WOS记录号 | WOS:000803450600001 |
资助机构 | National Natural Science Foundation of China |
源URL | [http://ir.psych.ac.cn/handle/311026/42749] |
专题 | 心理研究所_中国科学院心理健康重点实验室 |
通讯作者 | Shi, Jinli |
作者单位 | 1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing 100083, Peoples R China 2.Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing 100007, Peoples R China 3.Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 102488, Peoples R China |
推荐引用方式 GB/T 7714 | Zhao, Chengbowen,Wei, Xiaojia,Guo, Jianyou,et al. Dose Optimization of Anxiolytic Compounds Group in Valeriana jatamansi Jones and Mechanism Exploration by Integrating Network Pharmacology and Metabolomics Analysis[J]. BRAIN SCIENCES,2022,12(5):21. |
APA | Zhao, Chengbowen.,Wei, Xiaojia.,Guo, Jianyou.,Ding, Yongsheng.,Luo, Jing.,...&Shi, Jinli.(2022).Dose Optimization of Anxiolytic Compounds Group in Valeriana jatamansi Jones and Mechanism Exploration by Integrating Network Pharmacology and Metabolomics Analysis.BRAIN SCIENCES,12(5),21. |
MLA | Zhao, Chengbowen,et al."Dose Optimization of Anxiolytic Compounds Group in Valeriana jatamansi Jones and Mechanism Exploration by Integrating Network Pharmacology and Metabolomics Analysis".BRAIN SCIENCES 12.5(2022):21. |
入库方式: OAI收割
来源:心理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。